Technichem Organics appoints Asim Pandya as Independent Director

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Asim Pandya appointed as Non-Executive Independent Director for a 5-year term
  • Appointment effective from July 29, 2026, confirmed at AGM on September 24, 2026
  • Pandya brings over 36 years of experience in legal practice and academia
  • Holds no shareholding in Technichem and has no relationship with existing directors
powered bylight_fuzz_icon
51785874

*this image is generated using AI for illustrative purposes only.

Technichem Organics Limited appointed Asim Pandya as a Non-Executive Independent Director for a 5-year term, effective July 29, 2026. The appointment was ratified by shareholders during the company's 30th Annual General Meeting held on September 24, 2026.

This move strengthens the board's legal and compliance oversight capabilities. Pandya brings over 36 years of experience in the legal profession, adding significant expertise to the company's governance framework. The appointment was initially approved by the Board of Directors on July 29, 2026, and subsequently confirmed by members in accordance with SEBI regulations.

Profile of the Appointed Director

Asim Pandya holds a DIN of 10627198. He is a graduate with a Master of Law degree. His professional background is rooted deeply in the legal sector, where he has practiced across diverse branches of law. Beyond his practice, he is recognized as an academician and scholar, having authored several law books covering five different subjects. His reputation within the legal fraternity is noted for ethical conduct and scholarly contribution.

The following table outlines the key details of the appointment:

Parameter Details
Name Asim Pandya
Category Non-Executive Independent Director
Term 5 years
Effective Date July 29, 2026
Shareholding NIL
Relationship Not related to any Director/KMP

Governance and Compliance Details

The appointment complies with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Technichem confirmed that Pandya holds no shares in the company and has no familial relationship with any existing Directors or Key Managerial Personnel. Furthermore, the company affirmed that he is not debarred from holding the office of director by any SEBI order or other regulatory authority. The reason for this specific filing is the confirmation of the appointment originally made by the Board.

Historical Stock Returns for Technichem Organics

1 Day5 Days1 Month6 Months1 Year5 Years
+4.09%0.0%-30.47%0.0%-15.88%-25.97%

How might Pandya's extensive legal background influence Technichem's future litigation strategy and regulatory compliance posture?

Will the addition of a non-executive independent director with academic credentials lead to changes in the company's corporate governance policies or board committee structures?

What specific operational or strategic challenges is Technichem facing that necessitated strengthening its legal oversight capabilities at this time?

Technichem Organics FY26 Results: Net profit falls 32% to ₹272.3 lakh

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights
  • Net profit fell 32% YoY to ₹272.26 lakh in FY26
  • Revenue remained flat at ₹5,655.79 lakh
  • Operating cash flow turned positive at ₹348.46 lakh
  • Capital work-in-progress rose to ₹478.41 lakh
  • No dividend recommended for the year
powered bylight_fuzz_icon
48846031

*this image is generated using AI for illustrative purposes only.

Technichem Organics reported a 32% decline in net profit for the financial year ended March 31, 2026, driven by higher operating costs despite flat revenue. The Ahmedabad-based specialty chemicals manufacturer will hold its 30th Annual General Meeting (AGM) on September 24, 2026.

The company posted a profit after tax of ₹272.26 lakh for FY26, down from ₹402.88 lakh in the previous year. Revenue from operations remained largely stable at ₹5,655.79 lakh, compared to ₹5,678.23 lakh in FY25. The Board has not recommended any dividend for the year under review.

Financial Performance

The decline in profitability occurred even as top-line growth stagnated. Profit before interest and depreciation fell 31% to ₹570.74 lakh from ₹825.88 lakh in the prior year. Finance costs decreased to ₹121.40 lakh from ₹144.77 lakh, reflecting reduced debt obligations following the company's Initial Public Offer (IPO).

Metric FY26 FY25 Change
Revenue from operations ₹5,655.79 lakh ₹5,678.23 lakh -0.4%
Profit before tax ₹268.61 lakh ₹517.96 lakh -48.1%
Net profit after tax ₹272.26 lakh ₹402.88 lakh -32.4%

What the Numbers Show

A significant divergence exists between the company's operating cash flows and its net profit position. While net profit contracted sharply, operating cash flow swung positive to ₹348.46 lakh from an outflow of ₹701.55 lakh in FY25. This improvement was primarily driven by a ₹210.36 lakh increase in trade payables, suggesting the company extended payment terms to suppliers to fund working capital requirements amid inventory buildup. Inventories rose by ₹300.71 lakh during the period.

Capital Expenditure and IPO Utilization

The company utilized proceeds from its January 2025 IPO, which raised ₹25.24 crore, to repay borrowings and fund general corporate purposes. Capital work-in-progress increased significantly to ₹478.41 lakh from ₹81.98 lakh, indicating ongoing capacity expansion efforts. The Board confirmed that funds raised through the IPO have been utilized for their intended purposes without deviation.

Corporate Governance and AGM

The 30th AGM will be held via video conferencing. Shareholders will vote on the reappointment of Mr. Anilkumar J. Pandya, who retires by rotation, and the appointment of Mr. Asim Pandya as an Independent Director for a five-year term. Ms. Jaina Y. Mehta resigned as an Independent Director effective July 7, 2026.

Historical Stock Returns for Technichem Organics

1 Day5 Days1 Month6 Months1 Year5 Years
+4.09%0.0%-30.47%0.0%-15.88%-25.97%

How will the significant increase in capital work-in-progress impact Technichem Organics' revenue growth trajectory once the new capacity expansion is fully operational?

What specific strategies will management employ to reverse the margin compression caused by rising operating costs while maintaining flat revenue?

Will the extension of payment terms to suppliers, which boosted operating cash flow, strain supplier relationships or lead to tighter credit terms in future quarters?

More News on Technichem Organics

1 Year Returns:-15.88%